ALK-Abelló A/S (AKBLF) Shareholder/Analyst Call Transcript

ALK-Abelló A/S, a Danish allergy immunotherapy company, held a shareholder and analyst call discussing financials and pipeline developments. The company specializes in allergy treatment products, making this relevant to health and markets investors. The transcript is published via Seeking Alpha.